ASX - By Stock
|
MSB |
Re:
Ann: Information For Retail Shareholders
|
|
antibody
|
541 |
119K |
4 |
09/12/23 |
09/12/23 |
ASX - By Stock
|
541
|
119K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
18 |
09/12/23 |
09/12/23 |
ASX - By Stock
|
5.4K
|
2.7M
|
18
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
19 |
08/12/23 |
08/12/23 |
ASX - By Stock
|
5.4K
|
2.7M
|
19
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
13 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
5.4K
|
2.7M
|
13
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
antibody
|
10K |
3.0M |
8 |
06/12/23 |
06/12/23 |
ASX - By Stock
|
10K
|
3.0M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
antibody
|
10K |
3.0M |
8 |
06/12/23 |
06/12/23 |
ASX - By Stock
|
10K
|
3.0M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
antibody
|
10K |
3.0M |
20 |
06/12/23 |
06/12/23 |
ASX - By Stock
|
10K
|
3.0M
|
20
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
19 |
06/12/23 |
06/12/23 |
ASX - By Stock
|
5.4K
|
2.7M
|
19
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Launches Entitlement Offer and Placement
|
|
antibody
|
166 |
51K |
9 |
04/12/23 |
04/12/23 |
ASX - By Stock
|
166
|
51K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
17 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
5.4K
|
2.7M
|
17
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
16 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
5.4K
|
2.7M
|
16
|
|
ASX - By Stock
|
MSB |
Penny Trades
|
|
antibody
|
1 |
500 |
7 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
1
|
500
|
7
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
24 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
5.4K
|
2.7M
|
24
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
22 |
28/11/23 |
28/11/23 |
ASX - By Stock
|
5.4K
|
2.7M
|
22
|
|
ASX - By Stock
|
MSB |
Re:
MSB - ASX Charts
|
|
antibody
|
7 |
2.2K |
9 |
28/11/23 |
28/11/23 |
ASX - By Stock
|
7
|
2.2K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
15 |
25/11/23 |
25/11/23 |
ASX - By Stock
|
5.4K
|
2.7M
|
15
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
15 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
5.4K
|
2.7M
|
15
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
10 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
5.4K
|
2.7M
|
10
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
18 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
5.4K
|
2.7M
|
18
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
12 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
5.4K
|
2.7M
|
12
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
15 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
5.4K
|
2.7M
|
15
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
15 |
21/11/23 |
21/11/23 |
ASX - By Stock
|
5.4K
|
2.7M
|
15
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
antibody
|
10K |
3.0M |
9 |
21/11/23 |
21/11/23 |
ASX - By Stock
|
10K
|
3.0M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
antibody
|
10K |
3.0M |
14 |
21/11/23 |
21/11/23 |
ASX - By Stock
|
10K
|
3.0M
|
14
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
antibody
|
10K |
3.0M |
6 |
21/11/23 |
21/11/23 |
ASX - By Stock
|
10K
|
3.0M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
antibody
|
10K |
3.0M |
10 |
21/11/23 |
21/11/23 |
ASX - By Stock
|
10K
|
3.0M
|
10
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
21 |
21/11/23 |
21/11/23 |
ASX - By Stock
|
5.4K
|
2.7M
|
21
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
16 |
18/11/23 |
18/11/23 |
ASX - By Stock
|
5.4K
|
2.7M
|
16
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
16 |
17/11/23 |
17/11/23 |
ASX - By Stock
|
5.4K
|
2.7M
|
16
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
17 |
16/11/23 |
16/11/23 |
ASX - By Stock
|
5.4K
|
2.7M
|
17
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
17 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
5.4K
|
2.7M
|
17
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
9 |
14/11/23 |
14/11/23 |
ASX - By Stock
|
5.4K
|
2.7M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
29 |
14/11/23 |
14/11/23 |
ASX - By Stock
|
5.4K
|
2.7M
|
29
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
22 |
11/11/23 |
11/11/23 |
ASX - By Stock
|
5.4K
|
2.7M
|
22
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
20 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
5.4K
|
2.7M
|
20
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
23 |
09/11/23 |
09/11/23 |
ASX - By Stock
|
5.4K
|
2.7M
|
23
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
2 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
5.4K
|
2.7M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
7 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
5.4K
|
2.7M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
21 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
5.4K
|
2.7M
|
21
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
26 |
07/11/23 |
07/11/23 |
ASX - By Stock
|
5.4K
|
2.7M
|
26
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
antibody
|
184 |
48K |
3 |
05/11/23 |
05/11/23 |
ASX - By Stock
|
184
|
48K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
6 |
04/11/23 |
04/11/23 |
ASX - By Stock
|
5.4K
|
2.7M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
24 |
04/11/23 |
04/11/23 |
ASX - By Stock
|
5.4K
|
2.7M
|
24
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
23 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
5.4K
|
2.7M
|
23
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
20 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
5.4K
|
2.7M
|
20
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
31 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
5.4K
|
2.7M
|
31
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
18 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
5.4K
|
2.7M
|
18
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
19 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
5.4K
|
2.7M
|
19
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
antibody
|
17K |
6.8M |
21 |
29/10/23 |
29/10/23 |
ASX - By Stock
|
17K
|
6.8M
|
21
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
17 |
28/10/23 |
28/10/23 |
ASX - By Stock
|
5.4K
|
2.7M
|
17
|
|